Stay updated on Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.

Latest updates to the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page
- Check7 days agoChange DetectedUI updates include a glossary display toggle, and new labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', plus 'No FEAR Act Data'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check43 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.2 has been added. The previous Revision: v3.3.1 is replaced on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and the page revision is shown as v3.3.1, replacing the previous text that referenced v3.2.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the government funding status notice from the page, eliminating information about funding-related updates and delays. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedScreenshots show only minor formatting/layout updates to the Study Details page with no changes to core data such as eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.